Peter R U, Korting H C
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, München.
Arzneimittelforschung. 1991 Aug;41(8):852-4.
Both systemic and topical application of ketoconazole (CAS 65277-42-1) have been found effective in seborrhoeic dermatitis. The topical application of 2% ketoconazole in a cream base in particular has so far only once been compared to the application of the vehicle. Statistical analysis, however, has only been descriptive. In the present trial including 60 patients 2% ketoconazole cream (Nizoral) and a bland cream have been compared in a randomised, controlled fashion. Both erythema and scaling were found markedly more reduced in the verum group (p = 0.003 and p = 0.006, resp.). Hence the topical application of 2% ketoconazole cream can be considered as rational treatment of seborrhoeic dermatitis the more so as the application of the drug was well tolerated.
酮康唑(化学物质登记号:65277-42-1)的全身应用和局部应用均已被证实对脂溢性皮炎有效。特别是2%酮康唑乳膏剂的局部应用,迄今为止仅与赋形剂的应用进行过一次比较。然而,统计分析仅为描述性的。在本次纳入60例患者的试验中,对2%酮康唑乳膏(采乐)和一种空白乳膏进行了随机对照比较。结果发现,试验组的红斑和脱屑均明显减轻(分别为p = 0.003和p = 0.006)。因此,2%酮康唑乳膏的局部应用可被视为脂溢性皮炎的合理治疗方法,尤其是该药物的应用耐受性良好。